CA2461258C - Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes - Google Patents

Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes Download PDF

Info

Publication number: CA2461258C
Authority: CA; Canada
Prior art keywords: solvent; reinforcement member; mold; tissue; solution
Prior art date: 2004-03-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2461258A

Other languages

English (en)

Other versions

CA2461258A1 (fr

Inventor

Iksoo Chun

Dennis D. Jamiolkowski

Kelly R. Brown

Julia Hwang

Francois Binette

Mora Carolynne Melican

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ethicon Inc

Original Assignee

Ethicon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-18

Filing date

2004-03-18

Publication date

2013-07-30

2004-03-18 Application filed by Ethicon Inc filed Critical Ethicon Inc

2004-03-18 Priority to CA2461258A priority Critical patent/CA2461258C/fr

2005-09-18 Publication of CA2461258A1 publication Critical patent/CA2461258A1/fr

2013-07-30 Application granted granted Critical

2013-07-30 Publication of CA2461258C publication Critical patent/CA2461258C/fr

2024-03-18 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000007943 implant Substances 0.000 title claims abstract description 102
238000000034 method Methods 0.000 title claims description 62
238000002360 preparation method Methods 0.000 title description 4
239000006260 foam Substances 0.000 claims abstract description 61
230000002787 reinforcement Effects 0.000 claims abstract description 57
239000002904 solvent Substances 0.000 claims abstract description 57
229920000642 polymer Polymers 0.000 claims abstract description 55
230000003014 reinforcing effect Effects 0.000 claims abstract description 45
229920001577 copolymer Polymers 0.000 claims abstract description 22
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims abstract description 21
238000010791 quenching Methods 0.000 claims abstract description 20
230000000171 quenching effect Effects 0.000 claims abstract description 19
238000007710 freezing Methods 0.000 claims abstract description 17
230000008014 freezing Effects 0.000 claims abstract description 17
238000000137 annealing Methods 0.000 claims abstract description 16
238000004519 manufacturing process Methods 0.000 claims abstract description 12
229920000249 biocompatible polymer Polymers 0.000 claims abstract description 4
210000001519 tissue Anatomy 0.000 claims description 65
239000007787 solid Substances 0.000 claims description 22
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 20
210000000988 bone and bone Anatomy 0.000 claims description 16
239000000203 mixture Substances 0.000 claims description 15
239000002245 particle Substances 0.000 claims description 15
-1 poly(amino acids) Polymers 0.000 claims description 15
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 4
229920003232 aliphatic polyester Polymers 0.000 claims description 4
239000001110 calcium chloride Substances 0.000 claims description 4
229910001628 calcium chloride Inorganic materials 0.000 claims description 4
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
229920002472 Starch Polymers 0.000 claims description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
239000010935 stainless steel Substances 0.000 claims description 3
229910001220 stainless steel Inorganic materials 0.000 claims description 3
235000019698 starch Nutrition 0.000 claims description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
229920000936 Agarose Polymers 0.000 claims description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
229920002101 Chitin Polymers 0.000 claims description 2
229920001661 Chitosan Polymers 0.000 claims description 2
229910000684 Cobalt-chrome Inorganic materials 0.000 claims description 2
239000005715 Fructose Substances 0.000 claims description 2
229930091371 Fructose Natural products 0.000 claims description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
108010010803 Gelatin Proteins 0.000 claims description 2
108010076876 Keratins Proteins 0.000 claims description 2
102000011782 Keratins Human genes 0.000 claims description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
239000004952 Polyamide Substances 0.000 claims description 2
239000004698 Polyethylene Substances 0.000 claims description 2
239000002202 Polyethylene glycol Substances 0.000 claims description 2
229920001710 Polyorthoester Polymers 0.000 claims description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
229930006000 Sucrose Natural products 0.000 claims description 2
229910001069 Ti alloy Inorganic materials 0.000 claims description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
229940072056 alginate Drugs 0.000 claims description 2
229920000615 alginic acid Polymers 0.000 claims description 2
235000010443 alginic acid Nutrition 0.000 claims description 2
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
239000001506 calcium phosphate Substances 0.000 claims description 2
229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
235000011010 calcium phosphates Nutrition 0.000 claims description 2
239000001913 cellulose Substances 0.000 claims description 2
229920002678 cellulose Polymers 0.000 claims description 2
239000010952 cobalt-chrome Substances 0.000 claims description 2
239000008121 dextrose Substances 0.000 claims description 2
229920002313 fluoropolymer Polymers 0.000 claims description 2
229920000159 gelatin Polymers 0.000 claims description 2
239000008273 gelatin Substances 0.000 claims description 2
235000019322 gelatine Nutrition 0.000 claims description 2
235000011852 gelatine desserts Nutrition 0.000 claims description 2
239000008103 glucose Substances 0.000 claims description 2
239000008101 lactose Substances 0.000 claims description 2
150000003891 oxalate salts Chemical class 0.000 claims description 2
229920001308 poly(aminoacid) Polymers 0.000 claims description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
229920001281 polyalkylene Polymers 0.000 claims description 2
229920002647 polyamide Polymers 0.000 claims description 2
229920000515 polycarbonate Polymers 0.000 claims description 2
239000004417 polycarbonate Substances 0.000 claims description 2
229920000573 polyethylene Polymers 0.000 claims description 2
229920001223 polyethylene glycol Polymers 0.000 claims description 2
239000004926 polymethyl methacrylate Substances 0.000 claims description 2
229920001296 polysiloxane Polymers 0.000 claims description 2
229920002635 polyurethane Polymers 0.000 claims description 2
239000004814 polyurethane Substances 0.000 claims description 2
229920002689 polyvinyl acetate Polymers 0.000 claims description 2
239000011118 polyvinyl acetate Substances 0.000 claims description 2
239000001103 potassium chloride Substances 0.000 claims description 2
235000011164 potassium chloride Nutrition 0.000 claims description 2
HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 claims description 2
239000011780 sodium chloride Substances 0.000 claims description 2
239000001509 sodium citrate Substances 0.000 claims description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
239000001433 sodium tartrate Substances 0.000 claims description 2
229960002167 sodium tartrate Drugs 0.000 claims description 2
235000011004 sodium tartrates Nutrition 0.000 claims description 2
239000008107 starch Substances 0.000 claims description 2
239000005720 sucrose Substances 0.000 claims description 2
239000010936 titanium Substances 0.000 claims description 2
229910052719 titanium Inorganic materials 0.000 claims description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
239000000463 material Substances 0.000 description 45
239000000243 solution Substances 0.000 description 43
210000002435 tendon Anatomy 0.000 description 40
210000000845 cartilage Anatomy 0.000 description 18
230000008439 repair process Effects 0.000 description 18
230000006378 damage Effects 0.000 description 16
238000004108 freeze drying Methods 0.000 description 16
210000004027 cell Anatomy 0.000 description 15
235000004879 dioscorea Nutrition 0.000 description 15
239000000835 fiber Substances 0.000 description 15
239000012779 reinforcing material Substances 0.000 description 14
230000008569 process Effects 0.000 description 13
210000000513 rotator cuff Anatomy 0.000 description 13
238000001356 surgical procedure Methods 0.000 description 12
239000011148 porous material Substances 0.000 description 11
230000008901 benefit Effects 0.000 description 10
208000014674 injury Diseases 0.000 description 10
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
208000027418 Wounds and injury Diseases 0.000 description 9
238000002513 implantation Methods 0.000 description 9
230000003902 lesion Effects 0.000 description 9
229920000954 Polyglycolide Polymers 0.000 description 8
210000001264 anterior cruciate ligament Anatomy 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
238000004090 dissolution Methods 0.000 description 8
229920001198 elastomeric copolymer Polymers 0.000 description 8
238000012545 processing Methods 0.000 description 8
230000017423 tissue regeneration Effects 0.000 description 8
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
229920001971 elastomer Polymers 0.000 description 7
210000003127 knee Anatomy 0.000 description 7
210000004872 soft tissue Anatomy 0.000 description 7
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
210000000481 breast Anatomy 0.000 description 6
239000000806 elastomer Substances 0.000 description 6
210000000968 fibrocartilage Anatomy 0.000 description 6
230000035876 healing Effects 0.000 description 6
210000003035 hyaline cartilage Anatomy 0.000 description 6
239000012633 leachable Substances 0.000 description 6
229920000747 poly(lactic acid) Polymers 0.000 description 6
YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 6
VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 5
208000026137 Soft tissue injury Diseases 0.000 description 5
229910052782 aluminium Inorganic materials 0.000 description 5
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
210000000629 knee joint Anatomy 0.000 description 5
239000004310 lactic acid Substances 0.000 description 5
235000014655 lactic acid Nutrition 0.000 description 5
230000007774 longterm Effects 0.000 description 5
102000008186 Collagen Human genes 0.000 description 4
108010035532 Collagen Proteins 0.000 description 4
238000005299 abrasion Methods 0.000 description 4
210000001188 articular cartilage Anatomy 0.000 description 4
229920001436 collagen Polymers 0.000 description 4
239000000470 constituent Substances 0.000 description 4
230000006870 function Effects 0.000 description 4
210000002758 humerus Anatomy 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
210000003041 ligament Anatomy 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
210000003903 pelvic floor Anatomy 0.000 description 4
239000004633 polyglycolic acid Substances 0.000 description 4
235000002639 sodium chloride Nutrition 0.000 description 4
238000012360 testing method Methods 0.000 description 4
208000037816 tissue injury Diseases 0.000 description 4
238000011282 treatment Methods 0.000 description 4
JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000000712 assembly Effects 0.000 description 3
238000000429 assembly Methods 0.000 description 3
235000011148 calcium chloride Nutrition 0.000 description 3
210000001612 chondrocyte Anatomy 0.000 description 3
230000007850 degeneration Effects 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
230000003628 erosive effect Effects 0.000 description 3
239000003292 glue Substances 0.000 description 3
238000003306 harvesting Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
238000002386 leaching Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000011068 loading method Methods 0.000 description 3
238000012792 lyophilization process Methods 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
201000008482 osteoarthritis Diseases 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
239000012783 reinforcing fiber Substances 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
239000000758 substrate Substances 0.000 description 3
238000011477 surgical intervention Methods 0.000 description 3
230000007704 transition Effects 0.000 description 3
230000000472 traumatic effect Effects 0.000 description 3
210000003932 urinary bladder Anatomy 0.000 description 3
JJTUDXZGHPGLLC-ZXZARUISSA-N (3r,6s)-3,6-dimethyl-1,4-dioxane-2,5-dione Chemical compound C[C@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-ZXZARUISSA-N 0.000 description 2
BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
KKGSHHDRPRINNY-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1.O=C1COCCO1 KKGSHHDRPRINNY-UHFFFAOYSA-N 0.000 description 2
206010007710 Cartilage injury Diseases 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
102000009123 Fibrin Human genes 0.000 description 2
108010073385 Fibrin Proteins 0.000 description 2
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
239000004606 Fillers/Extenders Substances 0.000 description 2
206010019909 Hernia Diseases 0.000 description 2
206010061223 Ligament injury Diseases 0.000 description 2
206010072970 Meniscus injury Diseases 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
229920002988 biodegradable polymer Polymers 0.000 description 2
239000004621 biodegradable polymer Substances 0.000 description 2
229920001222 biopolymer Polymers 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
210000003109 clavicle Anatomy 0.000 description 2
230000007547 defect Effects 0.000 description 2
210000005069 ears Anatomy 0.000 description 2
210000001162 elastic cartilage Anatomy 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
210000002744 extracellular matrix Anatomy 0.000 description 2
238000000605 extraction Methods 0.000 description 2
229950003499 fibrin Drugs 0.000 description 2
238000005187 foaming Methods 0.000 description 2
239000012634 fragment Substances 0.000 description 2
239000007789 gas Substances 0.000 description 2
229920001519 homopolymer Polymers 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
239000011261 inert gas Substances 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
230000005499 meniscus Effects 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000007170 pathology Effects 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
229920001610 polycaprolactone Polymers 0.000 description 2
239000004632 polycaprolactone Substances 0.000 description 2
239000004626 polylactic acid Substances 0.000 description 2
229920002959 polymer blend Polymers 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
238000011069 regeneration method Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
210000001991 scapula Anatomy 0.000 description 2
238000001291 vacuum drying Methods 0.000 description 2
230000002792 vascular Effects 0.000 description 2
UJGHGRGFKZWGMS-UHFFFAOYSA-N 1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1OCCCO1 UJGHGRGFKZWGMS-UHFFFAOYSA-N 0.000 description 1
102000016284 Aggrecans Human genes 0.000 description 1
108010067219 Aggrecans Proteins 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
208000006820 Arthralgia Diseases 0.000 description 1
206010061762 Chondropathy Diseases 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
206010011803 Cystocele Diseases 0.000 description 1
241001269524 Dura Species 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
201000004989 Enterocele Diseases 0.000 description 1
206010061258 Joint lock Diseases 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
208000012287 Prolapse Diseases 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
206010038084 Rectocele Diseases 0.000 description 1
208000024288 Rotator Cuff injury Diseases 0.000 description 1
208000013201 Stress fracture Diseases 0.000 description 1
206010042618 Surgical procedure repeated Diseases 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
208000030922 Tibial Meniscus injury Diseases 0.000 description 1
239000006096 absorbing agent Substances 0.000 description 1
210000000142 acromioclavicular joint Anatomy 0.000 description 1
210000002659 acromion Anatomy 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012867 bioactive agent Substances 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
239000005312 bioglass Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
210000003321 cartilage cell Anatomy 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
230000035606 childbirth Effects 0.000 description 1
239000002131 composite material Substances 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
230000005786 degenerative changes Effects 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000005553 drilling Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000004177 elastic tissue Anatomy 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
210000003195 fascia Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000006261 foam material Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
210000001624 hip Anatomy 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
150000001261 hydroxy acids Chemical class 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
210000001503 joint Anatomy 0.000 description 1
230000008407 joint function Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
150000002596 lactones Chemical class 0.000 description 1
210000000867 larynx Anatomy 0.000 description 1
210000002414 leg Anatomy 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
239000000696 magnetic material Substances 0.000 description 1
230000005541 medical transmission Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000003607 modifier Substances 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
239000004745 nonwoven fabric Substances 0.000 description 1
230000006911 nucleation Effects 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000036407 pain Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000035515 penetration Effects 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
210000004623 platelet-rich plasma Anatomy 0.000 description 1
229920001982 poly(ester urethane) Polymers 0.000 description 1
229920002627 poly(phosphazenes) Polymers 0.000 description 1
238000006068 polycondensation reaction Methods 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001299 polypropylene fumarate Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000000135 prohibitive effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
230000003938 response to stress Effects 0.000 description 1
238000007151 ring opening polymerisation reaction Methods 0.000 description 1
239000005060 rubber Substances 0.000 description 1
238000001878 scanning electron micrograph Methods 0.000 description 1
238000009991 scouring Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
235000011083 sodium citrates Nutrition 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
210000001562 sternum Anatomy 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000000859 sublimation Methods 0.000 description 1
230000008022 sublimation Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
201000004595 synovitis Diseases 0.000 description 1
210000001738 temporomandibular joint Anatomy 0.000 description 1
239000004753 textile Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
210000002303 tibia Anatomy 0.000 description 1
210000004353 tibial menisci Anatomy 0.000 description 1
238000012090 tissue culture technique Methods 0.000 description 1
230000008467 tissue growth Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000008736 traumatic injury Effects 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
238000005406 washing Methods 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/06—At least partially resorbable materials
- A61L17/10—At least partially resorbable materials containing macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Composite Materials (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Dispersion Chemistry (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

CA2461258A 2004-03-18 2004-03-18 Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes Expired - Fee Related CA2461258C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA2461258A CA2461258C (fr)	2004-03-18	2004-03-18	Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA2461258A CA2461258C (fr)	2004-03-18	2004-03-18	Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes

Publications (2)

Publication Number	Publication Date
CA2461258A1 CA2461258A1 (fr)	2005-09-18
CA2461258C true CA2461258C (fr)	2013-07-30

Family

ID=35006093

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2461258A Expired - Fee Related CA2461258C (fr)	2004-03-18	2004-03-18	Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes

Country Status (1)

Country	Link
CA (1)	CA2461258C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN109432510B (zh) *	2018-08-30	2023-07-25	上海市同仁医院	用于微血管减压术的特氟龙减压材料及手术垫片

2004
- 2004-03-18 CA CA2461258A patent/CA2461258C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2461258A1 (fr)	2005-09-18

Legal Events

Date	Code	Title	Description
2009-03-17	EEER	Examination request
2017-05-01	MKLA	Lapsed	Effective date: 20170320

Publication	Publication Date	Title
US7368124B2 (en)	2008-05-06	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
CA2521355C (fr)	2014-11-25	Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes
JP4480928B2 (ja)	2010-06-16	強化した組織移植片およびその製造および使用の方法
US8641775B2 (en)	2014-02-04	Viable tissue repair implants and methods of use
CA2445356C (fr)	2010-02-02	Structures biocompatibles pour la reparation de ligaments et de tendons
JP2002320631A (ja)	2002-11-05	軟質組織の修復および再生のための向上した構造的完全性を有する強化した発泡体移植片の使用方法
JP2006102503A5 (fr)	2012-05-10
EP1744796A1 (fr)	2007-01-24	Implant chirurgical a mailles
CA2461258A1 (fr)	2005-09-18	Methode de preparation d'implants tissulaires renforces, poreux et bioabsorbables et implants connexes